Protein S-nitrosylation is a reversible protein modification implicated in both physiological and pathophysiological regulation of protein function. In obesity, skeletal muscle insulin resistance is associated with increased Snitrosylation of insulin signaling proteins. Yet, whether adipose tissue is similarly affected in obesity, and if so, what are the causes and functional consequences of increased Snitrosylation in this tissue is unknown. Total protein S-nitrosylation was increased in intraabdominal adipose tissue of obese humans, and in high-fat fed or leptin-deficient ob/ob mice. Both the insulin receptor β-subunit and Akt were S-nitrosylated, correlating with body weight. Elevated protein and mRNA expression of iNOS, and decreased protein levels of thioredoxin reductase were associated with increased adipose tissue Snitrosylation. Cultured differentiated preadipocyte cell lines exposed to the NO donors GSNO or SNAP exhibited diminished insulinstimulated phosphorylation of Akt, but not of GSK3 nor of insulin-stimulated glucose uptake. Yet, the anti-lipolytic action of insulin was markedly impaired in both cultured adipocytes and in mice injected with GSNO prior to administration of insulin. In cells, impaired ability of insulin to diminish phosphorylated PKA substrates in response to isoproterenol suggested impaired insulininduced activation of PDE3B. Consistently, increased S-nitrosylation of PDE3B was detected in adipose tissue of high-fat-fed obese mice. Site-directed mutagenesis revealed that Cys768 and Cys1040, two putative sites for Snitrosylation adjacent to the substrate binding-site of PDE3B accounted for ~50% of its GSNO-induced S-nitrosylation.
Introduction
Proteins S-nitrosylation -the covalent attachment of NO to cysteine residues in the presence of O 2 to form S-nitrosothiol adducts -is increasingly recognized to constitute a prevalent protein modification regulating proteins' function and stability (1, 2) . Like other chemical reactions involving reactive oxygen and nitrogen species (ROS and RNS, respectively), protein Snitrosylation occurs under normal physiological conditions, but when augmented can contribute to pathophysiology (3) . Being a reversible modification, increased S-nitrosylation occurs as a consequence of increased NO generation by nitric oxide synthases (NOS), and/or by a diminution of de-nitrosylation processes (4) . The inducible NO synthase (iNOS), which is a highcapacity NOS expressed in inflammatory cells and in other cell types following exposure to inflammatory signals (5) , is strongly associated with increased (pathophysiological) levels of protein S-nitrosylation (6, 7) . In obesity, a condition now recognized to be associated with increased systemic and local inflammation (8) , increased iNOS expression has been documented in insulin-sensitive tissues in both rodents and humans (9) (10) (11) . In skeletal muscle the ensuing increase in protein S-nitrosylation, specifically of proteins along the insulin signaling cascade, was proposed to contribute to the induction of insulin resistance (12) . These include the insulin receptor β-subunit (IRβ), insulin receptor substrate 1 (IRS-1), and Akt. S-nitrosylation of IRβ and Akt in muscle attenuates their kinase activities, and S-nitrosylation of IRS-1 reduces its tissue expression (11, 12) . Prevention of Snitrosylation of these proteins by decreasing iNOS expression improved insulin action (12) . Consistently, targeted disruption of iNOS prevents whole-body and skeletal muscle insulin resistance in high fat fed (HFF) mice (13) . Moreover, lipopolysaccharide (LPS)-induced skeletal muscle insulin resistance and increased S-nitrosylation of IRβ and of IRS-1 were also prevented in iNOS _ / _ mice, suggesting the importance of iNOS-mediated S-nitrosylation in inflammation-induced muscle insulin resistance (14) . Finally, direct induction of protein Snitrosylation by administration of pharmacologic NO donors like GSNO or SNAP in non-obese mice also induced muscular insulin resistance, providing compelling evidence for the importance of increased S-nitrosylation as a mediator in the induction of insulin resistance in muscle (14, 15 ). Yet, whether increased Snitrosylation occurs in obesity in other major sites of insulin action like adipose tissue, and what are its source and functional consequence, remain largely unexplored.
Whereas the main physiological function of insulin in skeletal muscle is to induce glucose uptake and utilization, in adipose tissue (where these functions are also observed), the inhibition of lipolysis is particularly important for wholebody metabolic regulation. This effect of insulin is achieved via its classical "metabolic signaling cascade" involving IR, IRSs, PI 3-kinase and Akt, the latter activating phosphodiesterase 3B (PDE-3B) via phosphorylation on Ser273 (16) . PDE3B then reduces cellular cAMP levels, thereby diminishing the lipolytic activation mediated by PKA-induced regulation of various lipases and lipid-droplet associated proteins, such as the phosphorylation of hormone sensitive lipase (HSL) and perilipin (17) . In obesity, dysregulated lipolysis results in elevated levels of free fatty acids, which in turn contribute to impaired glucose and lipid metabolism in skeletal muscle and liver leading to insulin resistance (18) .
In this study we hypothesized that increased S-nitrosylation occurs in adipose tissue in obesity, and may contribute to obesityassociated insulin resistance of adipocytes. Given the importance of dys-regulated lipolysis in the pathogenesis of obesity-associated metabolic dysfunction, we assessed whether increased Snitrosylation in adipocytes specifically targets the anti-lipolytic action of insulin. Our results suggest this is indeed the case, and that PDE3B may constitute a specific target of increased Snitrosylation in adipocytes.
Experimental procedures
Materials -Tissue culture medium, serum, antibiotic solutions, and recombinant human insulin were obtained from Biological Industries (Beit-Haeemek, Israel). Anti-phosphotyrosine (4G10) antibody was used at 1:4000 dilution (Transduction laboratories); anti-pSer 473 PKB/Akt, anti-PKB/Akt, anti-pPKB/Akt substrates (PAS), anti-pPKA substrates, antipSer21/9 GSK-3α/β, anti-GSK3α/β and antiInsulin Receptor β (IR-β) antibodies (all from Cell Signaling, Beverly, MA) were used at 1:1000 dilution; anti-iNOS, anti-eNOS, antinNOS, anti-thioredoxin reductase 1 (Abcam, San Francisco, CA) were used at 1:1000 dilution; anti-IRS-1 and anti-IRS-2 antibodies (Upstate Biotechnology) were used at 1μg/ml dilution; anti-β-Actin was used at 1:5000 dilution and anti-FLAG was used at 1:1000 dilution (both from Sigma-Aldrich); anti-Perilipin and antihormone-sensitive lipase (HSL) antibodies were generated as previously described (19) . The NO donor S-Nitrosoglutathione (GSNO) was from Sigma-Aldrich, and S-nitroso-Nacetylpenicillamine (SNAP) was purchased from Alexis (San Diego, CA). Murine PDE3B FLAGtagged wild-type plasmid was kindly provided by Prof. Vincent Manganiello, Translation Medicine Branch, National Institutes of Health, Bethesda, MD. Anti-PDE3B was kindly provided by Prof. Eva Degerman, Lund University, Sweden. Human samples -All procedures were approved in advance by the Soroka University Medical Center Institutional Review Committee, and patients gave written informed consent prior to all procedures. Intra-abdominal (omental) fat biopsies were obtained from obese (body mass index -BMI ≥ 30 Kg/m 2 ) or non-obese BMI ≤ 26 Kg/m 2 ) men and women undergoing elective laparoscopic abdominal surgeries -mainly bariatric surgery or cholecystectomy -at the Soroka University Medical Center (Beer-Sheva, Israel) as described and characterized elsewhere (20) (21) (22) . Biopsies were immediately transferred to the lab and frozen in liquid nitrogen until further analyzed.
Animals and treatments -
The study was approved by Ben-Gurion University Institutional Animal Care and Use Committee, and was conducted according to the Israeli Animal Welfare Act following the guidelines of the Guide for care and Use of Laboratory Animals (National Research Council, 1996) . Male C57BL/6 mice and ob/ob mice were purchased from Harlan Laboratories (Rehovot, Israel). Animals were allowed free access to standard rodent chow and water. Diet-induced obesity was achieved by feeding 6 week old wild-type mice high-fat diet for 19 weeks. The high-fat diet consisted of 58.7% calories derived from fat, 25.5% from carbohydrate, and 15% from protein (TD.88137, Harlan Teklad, Madison, WI). At the end of the experiment mice were killed with CO 2 . Peri-epididymal fat pads were removed and immediately frozen in liquid nitrogen until further analysis. Acute treatment with GSNO (1.25mg) was performed by intra-peritoneal injection 30 min before insulin was administered for additional 15 min. Plasma free fatty acids (FFA) and glucose levels were measured as we previously described (23), using the ACS-ACOD-MEHA method kit (Wako Chemicals GmbH, Neuss, Germany) and FreeStyle glucometer (Abbott, Alameda, CA), respectively. Cell Culture and adipocyte-macrophage coculture -Differentiated mouse pre-adipocytes [either 3T3-L1 (ATCC, Manassas, VA) or epididymal pre-adipocyte cell line (24) ] were grown and differentiated to mature adipocytes as we previously described (24, 25) . After being serum-starved for 24h, cultured adipocytes were pretreated with or without 0.5 mM SNAP or 1 mM GSNO for additional 24h. Insulin stimulation was performed with 100 nM insulin for 10 min.
The macrophage cell line RAW264.7 was obtained from ATCC (Manassas, VA) and cultured in RPMI 1640 supplemented with L-glutamine (2mM), heatinactivated FBS (10%) and antibiotics. Coculture of adipocytes and macrophages was performed by trypsinizing RAW cells grown on a 15 cm plate onto a 15 cm dish of confluent differentiated epididymal adipocytes. The cells were co-cultured for 24 additional hours, and then stimulated (where indicated) with 1µM LPS for additional 24 hours. Control experiments for the co-culture were performed by mixing lysates from adipocytes and macrophages grown separately, each derived from a 15 cm dish.
Total and specific protein S-nitrosylation -Snitrosylation of proteins was detected using the biotin-switch technique (BST) as described previously (26) , with minor modifications. In this procedure free sulfhydryls are first blocked, followed by reducing S-NO and reacting them with biotin, which is then identified. Fat tissue (~100-500 mg) or cultured cells (~1500 μg protein) were extracted with ice-cold lysis buffer containing 25 mM Hepes, 50 mM NaCl, 1% NP-40, 0.5 mM PMSF and protease inhibitors (a 1:1,000 dilution of protease inhibitor mixture; Sigma). The extracts were adjusted to 0.5 mg/ml of protein with HEN buffer (100 mM Hepes, 1 mM EDTA, 0.1 mM neocuproine) followed by addition of freshly prepared S-methyl methanethiosulfonate (10% v/v in N,Ndimethylformamide) and SDS (25% v/v) to final concentrations of 0.1 and 2.5%, respectively. Following frequent vortexing at 50 °C for 20 min, proteins were precipitated with 3 volumes of acetone at -20 °C for 1 h. The proteins were recovered by centrifugation at 5,000 g for 5 min, followed by gentle rinsing of the pellet with 4 × 1 ml 70% acetone/H 2 O. The pellets were then resuspended in 240 μl of HEN buffer containing 1% SDS. For labeling, the blocked samples were mixed with 0.1 volume of biotin-HPDP (2.5 mg/ml in Me 2 SO) and 0.1 volume (20 mM) of freshly prepared sodium ascorbate in HEN buffer. Labeling reactions were performed in the dark at room temperature for 1 h. For direct detection of biotinylated proteins, 40-60 μg of each labeling reaction was resolved by non-reducing SDS-PAGE, followed by immunoblotting with anti-biotin antibody (Sigma, 1:500). To detect an individual Snitrosylated (SNO) protein from lysates, the labeling reaction was acetone-precipitated as previously described. The washed pellet was resuspended in 250 μl of HEN/10 (HEN diluted 10-fold into H 2 O) containing 1% SDS, followed by addition of 750 μl of neutralization buffer (25 mM HEPES, 100 mM NaCl, 1 mM ETDA, 1% Triton X-100, pH 7.5). This material was incubated overnight at 4°C with 50 μl of a streptavidinagarose slurry. The beads were washed with 4 × 1 ml of wash buffer (neutralization buffer + 500 mM NaCl), followed by 2 × 1 ml of neutralization buffer. The dried beads were eluted with 50 μl of HEN/10 + 1% β-mercaptoethanol at room temperature for 20 min. The eluted mixture was then analyzed by SDS-PAGE, followed by immunoblotting with specific protein antibody (anti-Akt, IRβ, PDE3B and Flag Ab).
To optimize the detection of endogenous PDE3B-SNO, specific minor modifications to the assay were used based on optimization experiments: i. starting material was 8 mg of total adipose tissue protein; ii. sodium ascorbate was used at 50 mM, instead of 20 mM. iii. time of labeling reaction was extended to 3h.
Site-directed mutagenesis and cell TransfectioncDNAs for mutants of Flag-tagged PDE3B (C275A, C299A, C768A, C777A and C1040A), in which cysteine was replaced by alanine, were generated by QuikChange II XL Site-Directed mutagenesis Kit (Stratagene, Santa clara, CA). Human embryonic Kidney (HEK) 293T cells (ATCC, Manassas, VA) were grown in DMEM supplemented with 10% heat-inactivated foetal bovine serum (FBS). Cells were transfected using TurboFect in vitro Transfection Reagent (Fermentas Life Sciences). 48 h later cells were rinsed three times with PBS and scraped in icecold lysis buffer containing 25mM Hepes, 50 mM NaCl, 1% NP-40, 0.5 mM PMSF and protease inhibitors (a 1:1,000 dilution of protease inhibitor mixture; Sigma). The lysates were treated with 0-100 μM GSNO for 30 min in room temperature, and S-nitrosylation of PDE3B was assessed using anti-Flag Ab, as described above.
Cell Lysates and Western Blot analysis.
After treatments, the cells were rinsed three times with PBS and proteins were extracted as we previously described (25) . Protein concentration was determined using the BCA protein assay (Pierce). Protein samples were resolved on 10% SDS-polyacrylamide gel electrophoresis and subjected to Western blot, followed by quantification as described previously using ImageGauge software (Ver.4.0, Fuji Photo Film, Tokyo, Japan) (25) .
RNA extraction and RT-PCR.
Total RNA from fat pads was extracted with the RNeasy lipid tissue minikit (QIAGEN, Germantown, MD) and quantified with nanodrop. Then 2 μg of RNA were reverse transcribed with high-capacity cDNA reverse transcriptase kit (Applied Biosystems, Foster City, CA). Taqman system (Applied Biosystems) was used for real-time PCR amplification. Relative gene expression was obtained after normalization to 18S1 rRNA (Hs0392899_g1) using the formula 2^-ΔΔCt. The following primers were used: iNOS (Mm00440502_m1), eNOS (Mm00435217_m1), nNOS (Mm00435175_m1) and Txnrd1 (Mm00443675_m1).
Other assays -2-Deoxyglucose uptake measurements were performed as described previously (27) . Assays were performed for 10 min using 50 μM 2-deoxy-[3H] glucose (1 μCi/ml). For lipolysis adipocytes were stimulated with 5 nmol/l isoproterenol (Calbiochem, San Diego, CA) for 1h as we previously described (25) . Insulin (100 nmol/l) was included 15 min prior to and during the incubation with isoproteranol.
Glycerol was measured spectrophotometrically using a glycerol 3-phosphate oxidase trinder kit (Sigma).
Statistical analyses. Data are expressed as the mean ± SE. Statistical significance of differences between two groups (treatment vs. control) was evaluated using the Student's t test. The criterion for significance was set at P < 0.05. Correlation between S-nitrosylated Akt and IRβ/weight from obese human omental fat explants was done by Pearson's correlation test.
Results

Increased protein S-nitrosylation in adipose tissue in obesity -
To determine if obesity is associated with increased proteins Snitrosylation, adipose tissue from nutritional (high-fat fed, HFF) and genetic (leptin-deficient: ob/ob) mouse obesity models and human adipose tissue were used. Using the biotin switch assay (detailed in Methods), increased total protein Snitrosylation could be demonstrated in mouse adipose tissue of both HFF and ob/ob models ( Figure 1A ). Both models shared highly nitrosylated proteins compared to lean mice (for examples, bands at 60, 54 and ~45 kDa), occasional bands occurred only in one, but not in the other, model (see as an example a band seen at ~25 kDa only in HFF mice). On the other hand, intensity of some bands was decreased in ob/ob mice compared to the other two groups (for example, band of ~30 kDa). Specific protein S-nitrosylation could also be deteced: Akt was S-nitrosylated (Akt-SNO) in adipose tissue even in control (lean) mice, and its nitrosylation was further increased in response to a single dose of intraperitoneally injected GSNO, an NO donor ( Figure 1B) , consistent with reported findings in muscle (12) . Moreover, Akt-SNO was approximately 2.5-fold higher in adipose tissue of HFF compared to normal chowfed control mice ( Figure 1C) . In human omental adipose tissue, total protein S-nitrosylation was clearly increased in obese compared to nonobese persons ( Figure 1D ). Such notion was evident by both higher intensity of Snitrosylation signal from bands detectable also in the non-obese, or bands seen only in adipose tissue from obese persons. Consistent with the findings in mouse adipose tissue, S-nitrosylation of Akt could be detected in human adipose tissue (not shown), and the degree of Akt-SNO correlated with total body weight ( Figure 1E , upper graph). A similar trend was observed with the β-submit of the insulin receptor (IR), and the amount of Akt-SNO strongly inter-correlated (r 2 =0.606, p=0.004) with that of IRβ-SNO ( Figure 1E , lower graph), consistent with the total protein S-nitrosylation finding ( Figure 1D ).
To determine the potential mechanism(s) for increased S-nitrosylation in adipose tissue in obesity, and particularly to assess if it may result from increased NO production and/or diminished de-nitrosylation capacity, we assessed the expression of NOS isoforms and of thioredoxin reductase, respectively. Of the three NOS isoforms, only inducible NOS (iNOS) was increased at both protein and mRNA levels ( Figure 2A ). Thioredoxin reductase, an enzyme that converts oxidized to reduced thioredoxin and thus, participates in de-nitrosylation (28) , was elevated at the mRNA, but decreased at the protein level. Since adipose tissue is composed of different cell types, the elevated S-nitrosylation observed in the tissue may in fact represent a cross-talk phenomenon between adipocytes and nonadipocytes. In particular, iNOS shown to be increased in obesity ((10,13) and Figure 2A) , is a typical hallmark of activated macrophages (29, 30) . To address the possibility that increased S-nitrosylation in adipocytes requires activated macrophages we performed co-culture experiments. When grown separately, both cultured mouse intra-abdominal differentiated pre-adipocytes and RAW264.7 macrophages express Akt, but the expression of iNOS is observed only in the macrophages but not in the adipocyte cell line. In addition, iNOS is further increased by exposing macrophages to LPS ( Figure 2B ). As a next step, RAW264.7 macrophages were seeded onto adipocytes (cell contact co-culture, CC). Cells were then stimulated as indicated with LPS, and Akt Snitrosylation was assessed in lysates of the cocultured cell population. As a control for CC, cells were grown separately and stimulated as indicated with LPS, and lysates from both cultures were mixed post-cell treatment, as previously reported (31) and illustrated in Figure  2C ). Notably, a significant 2-fold increase in Snitrosylated Akt was only observed in adipocytemacrophage cell-contact (CC) culture that was stimulated with LPS ( Figure 2C ). The lack of detectable Akt-SNO in the mixed lysates control (ML) suggests that stimulated macrophages did not significantly nitrosylate their own Akt. Similar results were obtained in a co-culture apparatus in which macrophages were separated from the adipocytes by a permeable membrane (data not shown), suggesting that a diffusible factor from macrophages is responsible for the increased adipocyte Akt-SNO.
Thus, it is reasonable to propose that LPS-induced increase in NO, likely the result of iNOS activation in macrophages, nitrosylated Akt predominantly from the adipocytes. Collectively, these results suggest that increased total protein Snitrosylation in adipose tissue in obesity is likely contributed by changes in both sides of the Snitrosylation/de-nitrosylation balance, and that crosstalk between macrophages and adipocytes may underlie the augmented S-nitrosylation of specific proteins like Akt.
Increased S-nitrosylation in adipocytes interferes
with the anti-lipolytic action of insulin -In skeletal muscle increased S-nitrosylation was shown to diminish insulin signaling (12, 15) . To determine whether this similarly occurs in adipocytes, we studied the insulin signaling cascade in cultured adipocyte cell lines in which S-nitrosylation was directly induced using the NO donors GSNO and SNAP. Total protein Snitrosylation and S-nitrosylation of Akt were increased by the two NO donors ( Figure 3A) , an effect that was associated with decreased protein contents of IRS1 and IRS2 ( Figure 3B ). Yet, despite this decrease, insulin-stimulated tyrosine phosphorylation of bands corresponding to the IRSs or to the β subunit of the IR was not altered in response to either NO donor ( Figure 3C ). Further downstream the insulin signaling cascade, insulin-stimulated phosphorylation of Akt was mildly decreased, reaching a statistically-significant ~30% in SNAP-treated adipocytes ( Figure 3D) . However, the phosphorylation of GSK3 -an Akt substrate involved in the regulation of glycogen synthesis -was unaltered. Moreover, no significant attenuation of Akt-mediated phosphorylation could be observed on additional Akt substrates, as detected by blotting lysates with anti-phosphoAkt substrate (PAS) antibody, which recognizes phosphorylated proteins on their consensus Akt phosphorylation sequence (RxRxxS/T (16,32), Figure 3E ). Thus, although mild decreases in IRS protein content and in insulin-stimulated Akt phosphorylation could be observed in adipocytes with increased protein S-nitrosylation, this did not seem to manifest functionally on insulin regulation of several "classical" Akt substrates. Consistently, at the level of metabolic response to insulin, increased S-nitrosylation did not affect the ability of the hormone to stimulate glucose uptake activity ( Figure 4A ). Yet, since at the whole-body level insulin's most important metabolic action in adipocytes is the inhibition of lipolysis, we measured the effect of increased Snitrosylation on the anti-lipolytic action of insulin. As shown in Figure 4B , isoproterenol, a β adrenergic agonist, increased lipolysis ~10-fold in both GSNO or SNAP -treated, as in control adipocytes, as measured by glycerol release to the medium. Yet, whereas in control cells insulin inhibited this response by ~60%, this insulin effect was significantly attenuated by pretreatment of the cells with either GSNO or SNAP. Together, the results indicate that in adipocytes increased S-nitrosylation specifically diminishes the anti-lipolytic effect of insulin.
The antilipolytic action of insulin in adipocytes occurs by activation of phosphodiesterases, mainly PDE3B, which converts cAMP to AMP (16, (33) (34) (35) , thereby decreasing PKA-induced phosphorylation that mediates the stimulatory effect of isoproterenol on lipolysis. Using an anti-pPKA substrate antibody (directed against RRx-pS/T) it was evident that GSNO and SNAP interfered with the ability of insulin to attenuate isoproterenolinduced phosphorylation on PKA substrates ( Figure 4C ). By stripping and re-blotting the same membranes, we could verify that this indeed occurred specifically on two major PKA substrates in adipocytes that regulate lipolysis, hormone sensitive lipase (HSL) and the lipid droplet associated protein perilipin. With the latter, the diminished ability of insulin to negate PKA-induced phosphorylation was also evident by the migration of the perilipin bands -after treatment with NO donors perilipin still migrated at higher Mw even after insulin stimulation, consistent with its elevated phosphorylation state on PKA sites ( Figure 4C, right panel) .
To corroborate these direct effects of increased S-nitrosylation by NO donors in the invivo setting, we tested whether GSNO blunts insulin induced anti-lipolysis and/or glucose utilization in wild-type mice. Mice received an intra-peritoneal injection of GSNO or vehicle based on a previously published protocol (12) , and 30 min later insulin was administered. Glucose and free fatty acids (FFA) levels were measured at times 0 and 15 min of insulin administration, and the percent decrease in the level of either metabolite was calculated. Control mice (wild-type receiving vehicle injection and then insulin) exhibited a nearly 70% drop in FFA ( Figure 4E ), and 30% decrease in baseline glucose levels ( Figure 4D ), reflecting insulin's ability to inhibit lipolysis and increase glucose utilization, respectively. In ob/ob mice which develop severe insulin resistance, both metabolic responses to exogenous insulin were markedly impaired. In contrast, wild-type mice who received GSNO prior to insulin administration exhibited a significant attenuation of insulin's effect on FFA, but not on glucose levels. These results were consistent with the observations in adipocytes in culture, in which GSNO and SNAP inhibited insulin-induced anti-lipolysis, but not the stimulation of glucose uptake by the hormone (Figure 4A and 4B) . Collectively, these results suggest that the anti-lipolytic action of insulin is specifically targeted in adipose tissue/adipocytes subjected to increased protein S-nitrosylation.
PDE3B may constitute a direct target of Snitrosylation in adipocytes -
Using the biotinswitch assay, a significant increase in PDE3B-SNO could be detected in adipose tissue of HFF obese mice compared to chow-fed lean controls ( Figure 5A ). To further test the likelihood of PDE3B to undergo increased S-nitrosylation in adipocytes, lysates of cultured adipocytes were exposed to increasing doses of GSNO, and the sensitivity of endogenous PDE3B or Akt to SNO modification were determined by the biotin switch assay. Figure 5B demonstrates that under basal conditions S-nitrosylation was absent in PDE3B, while Akt exhibited a certain level of Snitrosylation even without exposure to GSNO (consistent with our observations in adipose tissue, Figure 1B and 1C) . Moreover, the sensitivity of PDE3B to GSNO-induced Snitrosylation seemed at least as high as, if not higher, than that of Akt: 5 μM GSNO already induced more than 10% of the maximal nitrosylation we observed on PDE3B at higher doses of GSNO, whereas Akt showed no increase above basal level with this concentration. Thus, endogenous PDE3B is more highly nitrosylated in adipose tissue from obese mice, and this protein is at least as sensitive as Akt, a well-documented target of increased Snitrosylation, to this protein modification.
PDE3B has several cysteines in its primary sequence. We chose to assess the contribution of 5 cysteines to PDE3B Snitrosylation -Cys275 and Cys299 are of interest since they are immediately adjacent to Ser273 and Ser296 that are phosphorylation targets of Akt and PKA, respectively (16) . Within the catalytic domain, we chose surface-exposed cysteines that were predicted to exist in nonboding state in the native protein sequence (based on Biocomp.Unibo prediction server, http://gpcr.biocomp.unibo,it), and thus, potentially amenable to react with NO. Sitedirected mutagenesis was used to individually mutate Cys275, Cys299, Cys768, Cys777 and Cys1040 to alanine. Of these residues, Cys768, Cys777 and Cys1040 are the most adjacent to the cAMP (substrate) binding pocket in the catalytic domain of PDE3B ( Figure 6A ). HEK293 cells were transfected with plasmids encoding Flagtagged wild-type PDE3B, or specific Cys to Ala site mutants, and the level of S-nitrosylation on PDE3B was assessed after exposure to GSNO. As shown in Figure 6B , wild-type PDE3B showed robust S-nitrosylation when cells were exposed to GSNO, and a similar level of PDE3B-SNO was observed with the Cys275Ala mutant. (Figure 5C ). Cys299Ala and Cys777Ala single-site mutants exhibited a small decrease in S-nitrosylation that did not reach statistical significance. Conversely, when either Cys768 or Cys1040 were mutated, GSNO-mediated Snitrosylation of PDE3B was markedly (though not fully) diminished. This effect could be demonstrable with both 10 and 100 μM GSNO ( Figure 6C ).
Discussion
Increased oxidative stress has been implicated in the pathogenesis of obesityassociated morbidity in general, and recently in adipose tissue dysfunction (36, 37 ). Yet, 'oxidative stress' designates a common term for an exceedingly large variety of mediators (reactive oxygen and/or nitrogen species), targets (proteins, nucleic acids, lipids) and of different types of chemical alterations (38) . Notably, attempts to crudely use antioxidant supplementation as a means of alleviating oxidative stress and thereby improving metabolic functions in obesity and diabetes has proven to be largely disappointing. Better definitions of the specific oxidative and/or nitrative species, their specific cellular target(s), and the specific type of chemical modification(s) such targets undergo are required for more efficient means of alleviating oxidative damage to be designed. The present study proposes that PDE3B, and/or the Akt-PDE3B interaction, are potential novel target(s) for increased S-nitrosylation in adipocytes in obesity, which may interfere with the anti-lipolytic action of insulin and can thus contribute to the development of insulin resistance Several oxidative/nitrative modifications of various cellular targets have been shown to be increased in obesity and/or diabetes and to contribute to their pathogenesis, including products of lipid peroxidation (like isoprostanes), DNA oxidation (deoxyguanosine), and protein carbonylation and tyrosine nitration (39) (40) (41) (42) . Increased S-nitrosylation of proteins is yet an additional specific form of nitrative modification of sulfhydryls. Like several of the modifications mentioned above, reversible S-nitrosylation may constitute a frequent post-translational modification of proteins used to regulate their function under normal physiological conditions, reminiscent of the more established regulation by phosphorylation/de-phosphorylation (4). Indeed, we found that adipose tissue of lean humans and animals, and cells under non-stressed conditions, exhibit a significant degree of total protein Snitrosylation. Some proteins like Akt have a "basal" level of S-nitrosylation. In such proteins an increased degree of S-nitrosylation may represent either a larger percentage of molecules nitrosylated on the same cysteine residue(s), or more cysteine residues modified per protein molecule. Indeed, the pattern of S-nitrosylated proteins in adipose tissue of obese humans or mice included bands migrating at the same Mw, but which exhibit increased signal. In skeletal muscle previous studies demonstrated that the degree of S-nitrosylation of Akt regulates its function under both physiological conditions (exercise) and in insulin resistance states (12, 43) . Here in adipose tissue and adipocytes, we could show that Akt is nitrosylated basally, but phosphorylation of its classical substrates, a measure of its function, was not markedly diminished in GSNO or SNAP-treated adipocytes.
Consistently, insulin-induced stimulation of glucose uptake that requires proper Akt signaling input was maintained in these cells. However, a different metabolic function of insulin that requires Akt -the inhibition of lipolysis, was indeed impaired by increasing S-nitrosylation. This was either secondarily to a modulation of Akt activity towards a specific target (PDE3B) rather than a general inactivation of the enzyme, and/or an interference with PDE3B activation by its direct S-nitrosylation. Unlike Akt, PDE3B may not be S-nitrosylated to a significant degree in basal conditions, and nitrosylation of its SH groups may therefore occur only under nonphysiological or diseased conditions. Indeed, observing the total pattern of S-nitrosylated proteins in adipose tissue it is possible to recognize bands not observable in lean controls, but which appear only under obese conditions. In the case of PDE3B, our data implicates two potential cysteine residues, Cys768 and Cys1040 as being responsible for a significant portion of the S-nitrosylation capacity of this protein in response to NO donors. Their proximity to the substrate binding site underscores the theoretical likelihood that their modification may indeed impair PDE3B activity, resulting in blunted antilipolytic response of adipocytes to insulin.
The mechanisms for increased Snitrosylation in adipose tissue in obesity may well involve both increased generation of NO that in turn would modify protein sulfhydryls, and diminution of de-nitrosylation processes (44, 45) . Of the latter process, thioredoxins are likely major enzymes catalyzing the denitrosylation of S-NO moieties on proteins. Their own red-ox recycling requires thioredoxin reductases, which we show here to be decreased at the protein level in adipose tissue in obesity. Complementarily, processes responsible for increased S-nitrosylation in obesity are more strongly supported: of the NOS isoforms, iNOS has a several-fold higher capacity to generate NO compared to nNOS and eNOS (46) . It is a major gene activated in inflammatory reactions that are now well accepted to be part of the milieu in the obese adipose tissue. We demonstrate here that indeed the combination of adipocytes and macrophages, the latter being the likely contributor of iNOS-mediated NO generation, is required for LPS-induced increase in Akt Snitrosylation. iNOS knockout mice have been shown to be protected from obesity-associated insulin resistance (13) . Yet, given our results that in adipocytes glucose uptake may not be impaired by increasing protein S-nitrosylation, this physiological effect of iNOS knockout, or of the insulin resistance induced by administering GSNO to mice, are likely the consequence of increased S-nitrosylation (of Akt) in skeletal muscle. Consistent with the unique functions of adipose tissue, our results suggest that the main metabolic consequence of increased Snitrosylation of adipose tissue proteins in obesity is the impairment of insulin-induced antilipolysis. Increased release of FFA from adipose tissue is a hallmark of the obese state and has been thought to play a central role in the pathogenesis of insulin resistance, fatty liver and dyslipidemia in obesity. Thus, it is tempting to speculate that means of preventing or reversing increased S-nitrosylation of the Akt-PDE3B axis in adipocytes may assist in alleviating obesityassociated dys-metabolism. Representative blots of Akt and iNOS protein expression in control or LPS (1µM/ml for 24h) -treated differentiated epididymal pre-adipocyte cell line or RAW264.7 macrophages. Below the blots are the results of densitometry analyses, expressed as the ratio of iNOS to β-actin, and presented as means ±SE of three independent experiments, with a value of 1 given to untreated RAW264.7 cells. *P< 0.05 vs. control. C. Effect of LPS and adipocyte-macrophage co-culture on Akt S-nitrosylation (Akt-SNO). RAW264.7 macrophages were seeded on top of cultured adipocyte monolayer, and the contact cell coculture system (CC) was stimulated as indicated with LPS. As a control, adipocytes and Raw macrophages were grown separately, stimulated separately as indicated with LPS, and lysates prepared from each cell culture were mixed (mixed lysates -ML), keeping the cell-type ratios identical to the CC systems. The amount of Akt-SNO and total Akt was then assessed as described in Methods. Shown are representative blots and densitometry analyses of 4 independent experiments, *P<0.05 vs. LPS-treated CT. Results of densitometry analysis of phosphorylated to total Akt and GSK3 are presented as means ± SE of 4 independent experiments performed in duplicate, with a value of 1 given to the intensity of the band achieved in insulin-stimulated control cells. *P< 0.05 vs. control with insulin.
Fig 4:
Increased S-nitrosylation in adipocytes interferes with the anti-lipolytic action of insulin Differentiated 3T3-L1 adipocytes were exposed to 1mM GSNO or 0.5 mM SNAP for 24 h. A. Following treatments, cells were rinsed and incubated in the absence (□) or presence (■) of 100 nmol/l insulin for an additional 20 min, after which 2-deoxyglucose (2DG) uptake was measured, as detailed in Materials and Methods. Results are means ± SE of three independent experiments, each performed in duplicate. B. Following treatments with NO donors, cells were rinsed and incubated in the absence (□) or presence of either 5 nmol/l isoproteranol (Iso) alone (■), or with 100 nmol/l insulin ( ) 15 min prior to and then for an additional 1 h in KRBH, after which glycerol release was assayed as described in Material and methods. Results are presented as means ± SE of three independent experiments performed at least in duplicate. *P< 0.005 between the bars indicated. C. Left: representative western blot analysis of phospho-PKA substrates of three independent experiments. Right: representative Western blot analysis for HSL and perilipin after striping and re-blotting of the membrane show in the left panel. Results of densitometry analysis of the inhibitory effect by insulin on the intensity of bands representing PKA-mediated phosphorylated perilipin are presented as means ± SE of three independent experiments, *P<0.05. D and E. C57BL6 mice were injected intra-peritoneally (i.p) with saline (□, n=7) or GSNO (■, n=7) 30 min before an additional i.p injection of 1 IU/Kg insulin for 15 min. ob/ob mice served as a positive control for blunted insulin response ( ). Blood samples were collected before and 15 min after the insulin injection. D. Results are presented as means ± SE of the percent of change in glucose between time 0 and 15 min after insulin administration, *P<0.05 vs. saline WT mice. E. Free fatty acids (FFA) level was determined as described in Material and methods. Results are presented as means ± SE of the percent of change in FFA with insulin, *P<0.05 vs. saline WT mice.
Fig 5: PDE3B is a potential target of S-nitrosylation in adipocytes
A. The degree of S-nitrosylation of PDE3B was determined in adipose tissue of HFF obese or chowfed lean control mice using the biotin switch assay, with several specific optimizations, as detailed in Methods. Shown are representative blots and densitometry analysis of results obtained from 3 chow fed and 6 HFF mice, p=0.04. B. Lysates of differentiated epididymal pre-adipocyte cell line were exposed to 0, 1, 5, 10 or 100 μM GSNO for 30 min in RT, after which S-nitrosylation of PDE3B and Akt were assessed. Densitometry of PDE3B-SNO and Akt-SNO per their respective total protein is derived from 5 independent experiments, and presented as the percent of intensity achieved with 100 μM GSNO. Vertical white line denotes splicing of the same membrane for clearer presentation. (47)), highlighting Cys-768 and Cys-1040 side chains as yellow spheres, 3-isobutyl-1-methylxanthine molecule (IBMX) at the substrate binding site is shown by red sticks, and magnesium ions are shown as green balls. (IBMX is a purine-derived, competitive inhibitor of most known PDEs). B. HEK 293T cells were transfected with plasmids encoding either the wild-type (WT) murine PDE3B, or specific cystein to alanine mutants generated by site-directed mutagenesis as described in Methods (C275A, C299A, C768A, C777A and C1040A). Lysates of transfected cells were exposed to GSNO 100 μM for 30 min in room temperature, S-nitrosylation was performed using the biotin switch assay, and PDE3B was identified using anti-FLAG antibodies. Results of densitometry analysis are presented as means ±SE of five independent experiments, with a value of 100% given to the intensity of the band achieved with lysates of WT-FLAG-PDE3B expressing cells after GSNO treatment. *P< 0.05 compared to WT without GSNO. **P<0.05 compared to GSNO-treated WT-PDE3B. Vertical white line denotes splicing of the same membrane for clearer presentation. C. HEK 293T cells were transfected with plasmids encoding either the wild-type (WT) murine PDE3B, or specific site-mutants C768A C1040A. Lysates of transfected cells were exposed to 10 or 100 μM GSNO for 30 min. Results of densitometry analysis are presented as means ±SE of five independent experiments, with a value of
